Cas:63098-90-8 3,4-dihydro-2H-quinoline-1-carboxamide manufacturer & supplier

We serve Chemical Name:3,4-dihydro-2H-quinoline-1-carboxamide CAS:63098-90-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,4-dihydro-2H-quinoline-1-carboxamide

Chemical Name:3,4-dihydro-2H-quinoline-1-carboxamide
CAS.NO:63098-90-8
Synonyms:1-CARBAMOYL-1,2,3,4-TETRAHYDROQUINOLINE;3,4-Dihydro-2H-chinolin-1-carbonsaeure-amid;3,4-dihydro-2H-quinoline-1-carboxylic acid amide
Molecular Formula:C10H12N2O
Molecular Weight:176.21500
HS Code:2933499090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:46.33000
Exact Mass:176.09500
LogP:2.28320

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-CARBAMOYL-1,2,3,4-TETRAHYDROQUINOLINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,4-dihydro-2H-quinoline-1-carboxylic acid amide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,4-dihydro-2H-quinoline-1-carboxylic acid amide Use and application,1-CARBAMOYL-1,2,3,4-TETRAHYDROQUINOLINE technical grade,usp/ep/jp grade.


Related News: While Stevanato has been in the headlines for its involvement in the fight against Covid-19—its factories immediately sprang to work producing vials and syringes for vaccines when Italy was still under lockdown in April 2020—vaccines only made up 4% of the company’s revenues in 2020 and 2019. 1,4-dimethyl-2-oxy-1,4-dihydro-tetrazol-5-one manufacturers This also includes experience for drug delivery systems, efficient teams, facilities, and production capabilities. rel-(2R,3S,4R)-1-(2-(dibutylamino)-2-oxoethyl)-4-(7-methoxybenzo[d][1,3]dioxol-5-yl)-2-(2-methoxyphenethyl)pyrrolidine-3-carboxylic acid suppliers Wang noted that Alexion could first introduce Alexion’s portfolio to China’s Guangdong-Hong Kong-Macau Greater Bay Area. A special program currently allows cross-border use of drugs and medical devices in the province of Guangdong—a wealthy territory with a large population—as long as the product is approved in Hong Kong. That offers an easy regulatory pathway for drugs already approved in the U.S. and the EU. (5-hydroperoxy-5-methylhexyl)benzene vendor & factory.